Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet

Topics

Medicine

Cancer Oncology

Pathology

Internal Medicine

Genetics

Show all topics

DOI

10.1016/s0140-6736(13)62292-8

License

CC-BY

Other Formats

PDF